Survival analysis showed that high Ki67 expression was inversely associated with disease-free survival (DFS) and overall survival (OS) in stage I lung adenocarcinoma (P < 0.05), but EGFR mutation status was not significantly associated with DFS and OS (P > 0.05). Here, MKI67 is linked to lung adenocarcinoma.